Assunta Melaccio

748 total citations
29 papers, 473 citations indexed

About

Assunta Melaccio is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Assunta Melaccio has authored 29 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Hematology. Recurrent topics in Assunta Melaccio's work include Multiple Myeloma Research and Treatments (10 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (4 papers). Assunta Melaccio is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), HER2/EGFR in Cancer Research (6 papers) and Advanced Breast Cancer Therapies (4 papers). Assunta Melaccio collaborates with scholars based in Italy, Australia and Germany. Assunta Melaccio's co-authors include Angelo Vacca, Roberto Ria, Antonio Giovanni Solimando, Ilaria Saltarella, Aurelia Lamanuzzi, Vanessa Desantis, Maria Antonia Frassanito, Vito Racanelli, Franco Dammacco and Maria Addolorata Mariggiò and has published in prestigious journals such as International Journal of Molecular Sciences, American Journal Of Pathology and The Journal of Pathology.

In The Last Decade

Assunta Melaccio

27 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Assunta Melaccio Italy 13 242 222 180 103 94 29 473
Aurelia Lamanuzzi Italy 14 309 1.3× 230 1.0× 147 0.8× 70 0.7× 120 1.3× 19 478
Timothy N. Trotter United States 14 163 0.7× 132 0.6× 240 1.3× 126 1.2× 98 1.0× 22 494
Norbert Grząśko Poland 13 285 1.2× 356 1.6× 237 1.3× 40 0.4× 54 0.6× 39 488
Paolo Ditonno Italy 9 239 1.0× 258 1.2× 201 1.1× 116 1.1× 69 0.7× 15 470
Antonio Cusmai Italy 11 197 0.8× 126 0.6× 292 1.6× 138 1.3× 109 1.2× 28 577
Natalie Stickel Germany 9 259 1.1× 79 0.4× 95 0.5× 184 1.8× 108 1.1× 11 550
James Berenson United States 11 310 1.3× 207 0.9× 250 1.4× 122 1.2× 41 0.4× 23 564
Luke B. Fletcher United States 8 168 0.7× 121 0.5× 64 0.4× 61 0.6× 51 0.5× 16 328
Alexander B. Sibley United States 12 124 0.5× 100 0.5× 171 0.9× 43 0.4× 71 0.8× 27 393
Normann Steiner Austria 14 219 0.9× 180 0.8× 191 1.1× 54 0.5× 44 0.5× 55 471

Countries citing papers authored by Assunta Melaccio

Since Specialization
Citations

This map shows the geographic impact of Assunta Melaccio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assunta Melaccio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assunta Melaccio more than expected).

Fields of papers citing papers by Assunta Melaccio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assunta Melaccio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assunta Melaccio. The network helps show where Assunta Melaccio may publish in the future.

Co-authorship network of co-authors of Assunta Melaccio

This figure shows the co-authorship network connecting the top 25 collaborators of Assunta Melaccio. A scholar is included among the top collaborators of Assunta Melaccio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assunta Melaccio. Assunta Melaccio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fedele, Palma, Matteo Landriscina, Antonio Cusmai, et al.. (2024). Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study. Cancers. 16(20). 3442–3442. 2 indexed citations
3.
Pinto, Antonio, Valeria Sanna, Assunta Melaccio, et al.. (2024). Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy. Pharmaceutics. 16(9). 1146–1146. 9 indexed citations
4.
Saltarella, Ilaria, Concetta Altamura, Assunta Melaccio, et al.. (2024). Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma. Biomedicine & Pharmacotherapy. 176. 116877–116877. 2 indexed citations
5.
Melaccio, Assunta, et al.. (2024). Therapeutic inhibition of isocitrate dehydrogenase mutations in glioma and cholangiocarcinoma: new insights and promises—a narrative review. Chinese Clinical Oncology. 13(5). 69–69. 1 indexed citations
6.
Santoro, Anna, Assunta Melaccio, Gennaro Gadaleta‐Caldarola, et al.. (2024). Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics. Expert Opinion on Drug Safety. 24(1). 9–16.
7.
Laface, Carmelo, Francesco Giuliani, Assunta Melaccio, et al.. (2023). The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions. Journal of Clinical Medicine. 12(18). 6012–6012. 1 indexed citations
8.
Giuliani, Francesco, Carmelo Laface, Assunta Melaccio, et al.. (2023). Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology. 30(6). 5769–5794. 13 indexed citations
9.
10.
Solimando, Antonio Giovanni, Assunta Melaccio, Angelo Vacca, & Roberto Ria. (2022). The bone marrow niche landscape: a journey through aging, extrinsic and intrinsic stressors in the haemopoietic milieu. Journal of Cancer Metastasis and Treatment. 6 indexed citations
11.
Desantis, Vanessa, Antonio Giovanni Solimando, Ilaria Saltarella, et al.. (2021). MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease. Cancers. 13(15). 3650–3650. 14 indexed citations
12.
Lamanuzzi, Aurelia, Ilaria Saltarella, Maria Antonia Frassanito, et al.. (2021). Thrombopoietin Promotes Angiogenesis and Disease Progression in Patients with Multiple Myeloma. American Journal Of Pathology. 191(4). 748–758. 11 indexed citations
13.
Ria, Roberto, Francesco Paolo Prete, Assunta Melaccio, et al.. (2020). Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?. Surgery. 169(1). 27–33. 5 indexed citations
14.
Ria, Roberto, Assunta Melaccio, Vito Racanelli, & Angelo Vacca. (2020). Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients. Journal of Clinical Medicine. 9(6). 1765–1765. 30 indexed citations
15.
Saltarella, Ilaria, Vanessa Desantis, Assunta Melaccio, et al.. (2020). Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma. Cells. 9(1). 167–167. 79 indexed citations
16.
Castella, Barbara, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, & Massimo Massaia. (2018). Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma. Frontiers in Oncology. 8. 508–508. 16 indexed citations
17.
Vacca, Angelo, et al.. (2017). Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial. Clinical Immunology. 191. 110–115. 63 indexed citations
18.
Iodice, Giuseppe, et al.. (2017). Long-term treatment with eribulin in heavily pretreated women with metastatic breast cancer: a case series. Future Oncology. 13(sup11). 25–33. 3 indexed citations
19.
Reale, Antonia, Assunta Melaccio, Aurelia Lamanuzzi, et al.. (2015). Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies. Stem Cells International. 2016(1). 7954580–7954580. 22 indexed citations
20.
Ria, Roberto, Antonia Reale, Assunta Melaccio, et al.. (2014). Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies. Clinical and Experimental Medicine. 15(2). 145–150. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurelia Lamanuzzi Breakdown of academic impact, for papers by Timothy N. Trotter Breakdown of academic impact, for papers by Norbert Grząśko Breakdown of academic impact, for papers by Paolo Ditonno Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Natalie Stickel Breakdown of academic impact, for papers by James Berenson Breakdown of academic impact, for papers by Luke B. Fletcher Breakdown of academic impact, for papers by Alexander B. Sibley Breakdown of academic impact, for papers by Normann Steiner
Rankless by CCL
2026